Clean Science and Technology IPO Subscription Details - Day 2
Last Updated: 15th December 2022 - 04:56 pm
Clean Science and Technology has been subscribed 4.28 times today on July 8, the second day of bidding.
Investors have put in bids for 5.26 crore equity shares vs. the offer size of 1.23 crore equity shares, the subscription data available on the exchanges showed.
The portion kept aside for qualified institutional buyers has subscribed 2.12 times, while non-institutional investors have put in bids 4.51 times their reserved portion, and retail bidders 5.42 times their reserved portion.
The Rs 1,546.6-crore public issue, a complete offer for sale, will close for subscription on July 9, 2021. The price band for the offer has been fixed at Rs 880-900 per equity share.
Clean Science & Technology IPO - subscription Status
Category | Subscription Status |
Qualified Institutional (QIB) | 2.12 Times |
Non-Institutional (NII) | 4.51 Times |
Retail Individual | 5.42 Times |
Total | 4.28 Times |
Also Check: Clean science and Technology IPO subscription Status - Day 1
About the Company:
Clean Science and Technology Limited manufactures functionally critical specialty chemicals such as Performance Chemicals, Pharmaceutical Intermediates, and FMCG Chemicals. The company was incorporated in 2003, and within 17 years of incorporation the company has grown to be the largest manufacturer globally of MEHQ, BHA, Anisole and 4-MAP, in terms of installed manufacturing capacities as of March 31, 2021. The company is among the few companies globally which is focused entirely on developing newer technologies using in-house catalytic processes that are eco-friendly and cost competitive. This has enabled the company to emerge as the largest manufacturer globally of certain specialty chemicals in terms of installed manufacturing capacities as of March 31, 2021. Some of these technologies have been developed and commercialized for the first time globally.
Trending on 5paisa
04
5paisa Research Team
Discover more of what matters to you.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.